...
首页> 外文期刊>Iranian Journal of Immunology >Association of HLA-DQA1*0101/2 and DQB1*0502 with Myasthenia Gravis in Southern Iranian Patients
【24h】

Association of HLA-DQA1*0101/2 and DQB1*0502 with Myasthenia Gravis in Southern Iranian Patients

机译:伊朗南部患者中HLA-DQA1 * 0101/2和DQB1 * 0502与重症肌无力的相关性

获取原文
           

摘要

Background: Myasthenia gravis is an autoimmune disorder of neuromuscular junction characterized by skeletal muscle weakness and fatigability. Different genes may control the induction and clinical presentation of this disease. Various HLA alleles are reported as predisposing or protective genetic elements in myasthenia gravis. Objective: The aim of this study was to investigate the probable association between HLA-DQ alleles and myasthenia gravis in southern Iranian patients. Methods: HLA-DQA1 and DQB1 alleles were determined in 104 sporadic patients with myasthenia gravis using polymerase chain reaction - restriction fragment length polymorphism method and the results were compared to 816 healthy controls. Results: HLA-DQA1*0101/2 (39.4%) and DQB1*0502 (21.6%) were the most frequent alleles in southern Iranian patients with myasthenia gravis. These alleles revealed positive associations with the disease with relative risks of 1.69 and 2.41, respectively. The most common haplotype was DQA1*0101/2-DQB1*0502 in these patients. Conclusion: According to the results of this study, DQA1*0101/2 and DQB1*0502 alleles might be considered as predisposing genetic factors to myasthenia gravis while DQA1*0501, DQB1*0301 and *0602/3 show protective roles against this disease.
机译:背景:重症肌无力是一种神经肌肉接头的自身免疫性疾病,其特征是骨骼肌无力和易疲劳。不同的基因可以控制该疾病的诱导和临床表现。据报道,各种HLA等位基因是重症肌无力的易感性或保护性遗传因素。目的:本研究的目的是调查伊朗南部患者中HLA-DQ等位基因与重症肌无力之间的可能关联。方法:采用聚合酶链反应-限制性酶切片段长度多态性方法对104例散发性重症肌无力患者的HLA-DQA1和DQB1等位基因进行检测,并与816例健康对照者进行比较。结果:HLA-DQA1 * 0101/2(39.4%)和DQB1 * 0502(21.6%)是伊朗南部重症肌无力患者中最常见的等位基因。这些等位基因显示与该疾病呈正相关,相对风险分别为1.69和2.41。在这些患者中,最常见的单倍型是DQA1 * 0101 / 2-DQB1 * 0502。结论:根据这项研究的结果,DQA1 * 0101/2和DQB1 * 0502等位基因可能被认为是重症肌无力的遗传因素,而DQA1 * 0501,DQB1 * 0301和* 0602/3显示出对这种疾病的保护作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号